Boston Massachusetts - Cambridge | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
| Stages | Pre-Seed, Seed, Early Stage, Series A, Series B |
| Investing | United States • Netherlands |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $770,000,000 |
About The Fund
Third Rock Ventures is a venture capital firm that specializes in the science of healthcare, focusing on areas such as BioTech, FinTech, Hardware and Manufacturing, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, and Pharmaceutical and Medicine. Founded in 2007 with headquarters at 29 Newbury St., 3rd Floor, Boston, MA 02116, this VC company also has an office in San Francisco, California. Their mission is to translate cutting-edge science into groundbreaking medical solutions that have the potential to significantly improve patient outcomes. They are particularly known as a venture studio with a robust platform for company formation, supporting entrepreneurial ventures from inception through their various funding stages—including Pre-Seed, Seed, Early Stage, Series A, and Series B rounds. With an asset under management footing of $770 million, Third Rock Ventures makes strategic investments ranging between $100,000 and $5,000,000, with a sweet spot of around $1,500,000 per venture. Some notable highlights from their portfolio include biopharmaceutical companies like Trace Neuroscience and Seaport Therapeutics, biotechnology firms such as Candid Therapeutics, Marea Therapeutics, and Clasp Therapeutics, and precision medicine creators like Synnovation Therapeutics. Additionally, Third Rock Ventures takes pride in the approval of gene therapies such as bluebird bio's Lyfgenia for sickle cell disease. A core value of Third Rock Ventures is to do the right thing, emphasizing inclusion and diversity within the workspace and the industry at large, as evidenced by their founding membership in the Bioscience & Investor Inclusion Group (BIIG). The firm has contributed to over 65 portfolio companies and more than 20 marketed products since its establishment, all with the singular priority of enhancing patient care.
What they say:
We invest in therapeutics. We are a venture studio focused on company formation that translates bleeding-edge science into medicines that transform patient lives.
Third Rock Ventures's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
